Alterity Therapeutics Limited - Sponsored ADR (ATHE)
(Real Time Quote from BATS)
$5.28 USD
+0.27 (5.39%)
Updated Aug 4, 2025 03:37 PM ET
After-Market: $5.28 0.00 (0.00%) 4:06 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Alterity Therapeutics Limited - Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ATHE 5.28 +0.27(5.39%)
Will ATHE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ATHE based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for ATHE
Alterity's (ATHE) ATH434 Gains U.S. FDA Fast Track Status for MSA
Appendix 4C -- Q4 FY25 Quarterly Cash Flow Report | ATHE Stock News
Alterity Therapeutics reports cash balance of A$40.66M as of June 30
12 Health Care Stocks Moving In Monday's Intraday Session
Alterity Therapeutics (ATHE) Reports Positive Trial Results for ATH434